Clariane Achieves Successful Bond Issue
Clariane has successfully completed a bond issuance of 400 million euros, marking a significant milestone for the company as it continues to strengthen its financial position. This bond, set to mature in five years, showcases the robust investor confidence in Clariane's ongoing strategic initiatives.
Investor Interest Highlights
This bond issue generated substantial interest, with an overwhelming order book exceeding 1.2 billion euros. The demand indicates a threefold oversubscription, reflecting strong support from both French and international Tier 1 institutional investors. Such robust backing positions Clariane favorably in the financial markets, facilitating its growth ambitions.
Long-term Financial Strategy
With the completion of this bond issue, Clariane effectively extends the average maturity of its debts while also securing an annual coupon of 7.875%. The intentions behind this strategic move align with Clariane's broader goal to enhance its financial structure and ensure normalized access to financing.
Recent Business Developments
In tandem with the bond issuance, Clariane announced the sale of its Petits-fils home care business, a crucial step in its ongoing efforts to refine its operational focus. This divestiture was finalized six months earlier than anticipated, further demonstrating Clariane's commitment to its financial strengthening plan initiated in November 2023, targeting a total of €1.5 billion in refinancing.
Use of Bond Proceeds
The net proceeds from this bond issuance will be directed towards refinancing existing debts, including the redemption of OCEANE bonds. This strategic allocation not only diminishes financial liabilities but showcases Clariane's proactive management of its debt portfolio.
Trading Plans for the Bonds
Clariane plans to apply for these bonds to be traded on the Global Exchange Market of Euronext Dublin. The expected settlement and trading admission date is set for June 27. This transition is anticipated to enhance the liquidity of the bonds, offering investors greater flexibility.
Leading the Issuance
The bond issuance process was adeptly managed by Morgan Stanley, acting as Joint Global Coordinator and Sole Active Bookrunner, while Société Générale contributed as the Co-Manager. Their expertise in capital markets plays a pivotal role in ensuring the successful placement of the bonds and cultivating investor relationships.
About Clariane
Clariane stands as the premier European community of care during times of vulnerability, operating across six countries and serving approximately 900,000 patients annually. With a dedicated workforce of 63,000 professionals, Clariane provides diverse services, including care homes and alternative living solutions.
A New Corporate Ethos
In a recent evolution, Clariane has embraced a purpose-driven approach, adopting a core principle that emphasizes “taking care of each person’s humanity in times of vulnerability.” This commitment reflects Clariane's dedication to providing compassionate and tailored care to individuals in need.
Future Outlook
As Clariane continues to innovate and adapt in the dynamic landscape of healthcare, the recent bond issuance signals a commitment to enhancing financial stability and pursuing growth opportunities. The company remains poised for significant advancements in its mission to elevate care standards across its operational spectrum.
Frequently Asked Questions
What was the total amount of the bond issued by Clariane?
Clariane successfully issued a bond totaling 400 million euros.
What is the purpose of the bond proceeds?
The net proceeds will be utilized to refinance existing debts, including the redemption of OCEANE bonds.
Who led the bond issuance for Clariane?
Morgan Stanley served as the Joint Global Coordinator and Sole Active Bookrunner for the bond issuance, with Société Générale as Co-Manager.
What does Clariane specialize in?
Clariane specializes in care services during vulnerable times, operating care homes, healthcare facilities, and alternative living solutions.
What is Clariane’s new corporate purpose?
The company’s corporate purpose emphasizes “taking care of each person’s humanity in times of vulnerability.”
